235 related articles for article (PubMed ID: 19368965)
21. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study.
Rabe KF; Atienza T; Magyar P; Larsson P; Jorup C; Lalloo UG
Lancet; 2006 Aug; 368(9537):744-53. PubMed ID: 16935685
[TBL] [Abstract][Full Text] [Related]
22. Fluticasone/formoterol combination therapy versus budesonide/formoterol for the treatment of asthma: a randomized, controlled, non-inferiority trial of efficacy and safety.
Bodzenta-Lukaszyk A; Buhl R; Balint B; Lomax M; Spooner K; Dissanayake S
J Asthma; 2012 Dec; 49(10):1060-70. PubMed ID: 23102189
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and tolerability of once-daily budesonide/formoterol pressurized metered-dose inhaler in adults and adolescents with asthma previously stable with twice-daily budesonide/ formoterol dosing.
Kerwin EM; Oppenheimer JJ; LaForce C; Parasuraman B; Miller CJ; O'Dowd L; Goldman M
Ann Allergy Asthma Immunol; 2009 Jul; 103(1):62-72. PubMed ID: 19663129
[TBL] [Abstract][Full Text] [Related]
24. Is the patient's baseline inhaled steroid dose a factor for choosing the budesonide/formoterol maintenance and reliever therapy regimen?
Aubier M; Haughney J; Selroos O; van Schayck OC; Ekström T; Ostinelli J; Buhl R
Ther Adv Respir Dis; 2011 Oct; 5(5):289-98. PubMed ID: 21586508
[TBL] [Abstract][Full Text] [Related]
25. Budesonide/formoterol maintenance and reliever therapy versus conventional best standard treatment in asthma in an attempted 'real life' setting.
Søes-Petersen U; Kava T; Dahle R; Lei Y; Dam N
Clin Respir J; 2011 Jul; 5(3):173-82. PubMed ID: 21679353
[TBL] [Abstract][Full Text] [Related]
26. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
O'Connor RD; Patrick DL; Parasuraman B; Martin P; Goldman M
J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
[TBL] [Abstract][Full Text] [Related]
27. Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma.
Kuna P; Creemers JP; Vondra V; Black PN; Lindqvist A; Nihlen U; Vogelmeier C
Respir Med; 2006 Dec; 100(12):2151-9. PubMed ID: 16701989
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness and safety of adjustable maintenance dosing with budesonide/formoterol turbuhaler compared with traditional fixed doses in bronchial asthma: a multi-centre Nigerian study.
Ige OM; Ohaju-Obodo JO; Chukwu C; Peters EJ; Okpapi J; Chukwuka C
Afr J Med Med Sci; 2010 Sep; 39(3):165-72. PubMed ID: 21416785
[TBL] [Abstract][Full Text] [Related]
29. Formoterol as needed with or without budesonide in patients with intermittent asthma and raised NO levels in exhaled air: A SOMA study.
Haahtela T; Tamminen K; Malmberg LP; Zetterström O; Karjalainen J; Ylä-Outinen H; Svahn T; Ekström T; Selroos O
Eur Respir J; 2006 Oct; 28(4):748-55. PubMed ID: 17012630
[TBL] [Abstract][Full Text] [Related]
30. The effects of inhaled budesonide and formoterol in combination and alone when given directly after allergen challenge.
Duong M; Gauvreau G; Watson R; Obminski G; Strinich T; Evans M; Howie K; Killian K; O'Byrne PM
J Allergy Clin Immunol; 2007 Feb; 119(2):322-7. PubMed ID: 17141859
[TBL] [Abstract][Full Text] [Related]
31. Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma.
Kelly MM; O'Connor TM; Leigh R; Otis J; Gwozd C; Gauvreau GM; Gauldie J; O'Byrne PM
J Allergy Clin Immunol; 2010 Feb; 125(2):349-356.e13. PubMed ID: 19969339
[TBL] [Abstract][Full Text] [Related]
32. Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness.
Green RH; Brightling CE; McKenna S; Hargadon B; Neale N; Parker D; Ruse C; Hall IP; Pavord ID
Eur Respir J; 2006 Jun; 27(6):1144-51. PubMed ID: 16455831
[TBL] [Abstract][Full Text] [Related]
33. Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients.
Busse WW; Shah SR; Somerville L; Parasuraman B; Martin P; Goldman M
J Allergy Clin Immunol; 2008 Jun; 121(6):1407-14, 1414.e1-6. PubMed ID: 18455221
[TBL] [Abstract][Full Text] [Related]
34. Do asthmatic smokers benefit as much as non-smokers on budesonide/formoterol maintenance and reliever therapy? Results of an open label study.
van Schayck OC; Haughney J; Aubier M; Selroos O; Ekström T; Ostinelli J; Buhl R
Respir Med; 2012 Feb; 106(2):189-96. PubMed ID: 22119455
[TBL] [Abstract][Full Text] [Related]
35. Combination budesonide/formoterol inhaler as maintenance and reliever therapy in Māori with asthma.
Pilcher J; Patel M; Smith A; Davies C; Pritchard A; Travers J; Black P; Weatherall M; Beasley R; Harwood M;
Respirology; 2014 Aug; 19(6):842-51. PubMed ID: 24889937
[TBL] [Abstract][Full Text] [Related]
36. Safety of budesonide/formoterol maintenance and reliever therapy in asthma trials.
Sears MR; Radner F
Respir Med; 2009 Dec; 103(12):1960-8. PubMed ID: 19815402
[TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy in Denmark--cost-effectiveness analysis based on five randomised controlled trials.
Wickstrøm J; Dam N; Malmberg I; Hansen BB; Lange P
Clin Respir J; 2009 Jul; 3(3):169-80. PubMed ID: 20298400
[TBL] [Abstract][Full Text] [Related]
38. Inflammatory and functional effects of increasing asthma treatment with formoterol or double dose budesonide.
Menezes MB; Teixeira AL; Terra Filho J; Vianna EO
Respir Med; 2008 Oct; 102(10):1385-91. PubMed ID: 18632258
[TBL] [Abstract][Full Text] [Related]
39. Budesonide/formoterol maintenance and reliever therapy in asthma control: acute, dose-related effects and real-life effectiveness.
Lin CH; Hsu JY; Hsiao YH; Tseng CM; Su VY; Chen YH; Yang SN; Lee YC; Su KC; Perng DW
Respirology; 2015 Feb; 20(2):264-72. PubMed ID: 25366969
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy.
Price D; Wirén A; Kuna P
Allergy; 2007 Oct; 62(10):1189-98. PubMed ID: 17845590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
